&w=3840&q=100)
India's active Covid-19 cases fall under 6,000; three deaths in 24 hours
Of the three fatalities, two were from Delhi and one from Kerala. All the deceased were elderly individuals with chronic health conditions.
Active Covid-19 cases have declined across most states, with 507 fewer new infections reported on Wednesday. Delhi recorded the highest number of fresh cases in the past day, adding 12 infections and taking its active case count to 632.
Kerala continues to report the highest number of active cases at 1,309, followed by Gujarat with 1,046. Maharashtra remains among the most affected states, with 5,443 active cases.
Karnataka saw the largest single-day drop, with 187 fewer cases, while Rajasthan reported a decline of 83 cases in the same period.
State Active Cases New Cases (Last 24 Hours) Deaths (Last 24 Hours)
Kerala 1,309 -75 1
Maharashtra 443 -46 0
Gujarat 1,046 -59 0
Delhi 632 +12 2
Rajasthan 219 -83 0
Karnataka 466 -187 0
Tamil Nadu 187 -37 0
PGIMER: Covid-19 under control in India
Covid-19 is currently under control in India, with no new cases reported over the past week, according to Dr Vivek Lal, Director of the Post Graduate Institute of Medical Education and Research (PGIMER).
Speaking to ANI, Dr Lal attributed the decline in cases to the robust vaccination drive led by Prime Minister Narendra Modi. 'We are fully prepared for Covid-19, but the situation is clearly improving. I don't think a single patient has tested positive in the last week,' he said.
Dr Lal credited India's ongoing vaccination campaign for maintaining immunity and reducing case severity.
Scientists monitor new subvariants behind latest surge
The National Institute of Virology (NIV) has begun genome sequencing and isolation of four new Omicron subvariants believed to be behind the recent spike in cases.
Genome sequencing helps determine the complete genetic makeup of viruses and track mutations that impact transmissibility and vaccine efficacy.
Dr Naveen Kumar, director of the Pune-based NIV, said this effort would assess whether existing vaccines remain effective or require updates. 'So far, the new variants do not appear to cause severe disease,' he noted.
He added that isolating the strains would aid in evaluating vaccine formulation, but any decision to update vaccines lies with policymakers following expert consultations.
Experts recommend targeted boosters, not mass drives
Public health experts have advised against a mass booster campaign, recommending targeted doses for high-risk groups such as the elderly, immunocompromised individuals, and those with chronic illnesses.
They said India's hybrid immunity—developed from both past infections and vaccinations—provides sufficient protection for the general population.
While the national outlook remains positive, officials cautioned that isolated clusters of infections are still emerging and should be monitored.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
43 minutes ago
- The Hindu
Content moderators for Big Tech unite to tackle mental trauma
Content moderators from the Philippines to Turkey are uniting to push for greater mental health support to help them cope with the psychological effects of exposure to a rising tide of disturbing images online. The people tasked with removing harmful content from tech giants like Meta Platforms or TikTok, report a range of noxious health effects from loss of appetite to anxiety and suicidal thoughts. "Before I would sleep seven hours," said one Filipino content moderator who asked to remain anonymous to avoid problems with their employer. "Now I only sleep around four hours." Workers are gagged by non-disclosure agreements with the tech platforms or companies that do the outsourced work, meaning they cannot discuss exact details of the content they are seeing. But videos of people being burned alive by the Islamic State, babies dying in Gaza and gruesome pictures from the Air India crash in June were given as examples by moderators who spoke to the Thomson Reuters Foundation. Social media companies, which often outsource content moderation to third parties, are facing increasing pressure to address the emotional toll of moderation. Meta, which owns Facebook, WhatsApp and Instagram, has already been hit with workers' rights lawsuits in Kenya and Ghana, and in 2020 the firm paid a $52 million settlement to American content moderators suffering long-term mental health issues. The Global Trade Union Alliance of Content Moderators was launched in Nairobi in April to establish worker protections for what they dub "a 21st century hazardous job", similar to the work of emergency responders. Their first demand is for tech companies to adopt mental health protocols, such as exposure limits and trauma training, in their supply chains. "They say we're the ones protecting the internet, keeping kids safe online," the Filipino worker said, "But we are not protected enough." Globally, tens of thousands of content moderators spend up to 10 hours a day scrolling through social media posts to remove harmful content, and the mental toll is well-documented. "I've had bad dreams because of the graphic content, and I'm smoking more, losing focus," said Berfin Sirin Tunc, a content moderator for TikTok in Turkey employed via Canadian-based tech company Telus, which also does work for Meta. In a video call with the Thomson Reuters Foundation, she said the first time she saw graphic content as part of her job she had to leave the room and go home. While some employers do provide psychological support, some workers say it is just for show, with advice to count numbers or do breathing exercises. Therapy is limited to either group sessions or a recommendation to switch off for a certain number of "wellness break" minutes. But taking them is another thing. "If you don't go back to the computer, your team leader will ask where are you and (say) that the queue of videos is growing," said Tunc, "Bosses see us just as machines." In emailed statements to the Thomson Reuters Foundation, Telus and Meta said the well-being of their employees is a top priority and that employees should have access to 24/7 healthcare support. Moderators have seen an uptick in violent videos. A report by Meta for the first quarter of 2025 showed a rise in the sharing of violent content on Facebook, after the company changed its content moderation policies in a commitment to "free expression." However, Telus said in its emailed response that internal estimates show that distressing material represents less than 5% of the total content reviewed. Adding to the pressure on moderators is a fear of losing jobs as companies shift towards artificial intelligence-powered moderation. Meta, which invested billions and hired thousands of content moderators globally over the years to police extreme content, scrapped its U.S. fact-checking programme in January, following the election of Donald Trump. In April, 2,000 Barcelona-based workers were sent home after Meta severed a contract with Telus. A Meta spokesperson said the company has moved the services that were being performed from Barcelona to other locations. "I'm waiting for Telus to fire me," said Tunc, "because they fired my friends from our union." Fifteen workers in Turkey are suing the company after being dismissed, they say, after organising a union and attending protests this year. A spokesperson for Telus said in an emailed response that the company "respects the rights of workers to organise". Telus said a May report by Turkey's Ministry of Labour found contract terminations were based on performance and it could not be concluded that the terminations were union-related. The Labour Ministry did not immediately respond to a request for comment. Moderators in low-income countries say that the low wages, productivity pressure and inadequate mental health support can be remedied if companies sign up to the Global Alliance's eight protocols. These include limiting exposure time, making realistic quotas and 24/7 counselling, as well as living wages, mental health training and the right to join a union. Telus said in its statement that it was already in compliance with the demands, and Meta said it conducts audits to check that companies are providing required on-site support. New European Union rules, such as the Digital Services Act, the AI Act and supply chain regulations which demand tech companies address risks to workers, should give stronger legal grounds to protect content moderators' rights, according to labour experts. "Bad things are happening in the world. Someone has to do this job and protect social media," said Tunc. "With better conditions, we can do this better. If you feel like a human, you can work like a human."
Indian Express
an hour ago
- Indian Express
Vaccine manufacturers' body, Serum Institute of India reaffirm COVID-19 vaccine safety
The Indian Vaccine Manufacturers Association (IVMA) has assured that all COVID-19 vaccines in India were approved for emergency use authorisation based on extensive evaluation in preclinical studies and human clinical trials. 'Patient safety and product quality are always prioritised during the vaccine development and its manufacture,' Dr G V J A Harshavardhan, Director General, IVMA, said in a statement released on Thursday. The statement sought to reassure the public on the safety and efficacy of COVID-19 vaccines. 'All COVID-19 vaccines in India were approved for emergency use authorisation [restricted use in emergency situations as per World Health Organization guidelines], he said, adding, 'These approvals were based on extensive evaluation in preclinical studies and human clinical trials, with positive results on safety, efficacy, and immunogenicity of these vaccines.' The IVMA statement comes in the backdrop of the Union health ministry saying on Wednesday that extensive studies by several agencies have 'conclusively established no linkages' between COVID-19 vaccines and sudden deaths. The Serum Institute of India also posted on X that the COVID-19 vaccines were safe and scientifically validated. 'Two large-scale studies by ICMR [Indian Council of Medical Research] and AIIMS [All India Institute of Medical Sciences], as cited by the Ministry of Health have found no link between Covid-19 vaccines and sudden deaths,' SII said. The IVMA statement also noted that prior to their release, all COVID-19 vaccines were tested extensively for safety by the manufacturers and were also provided Batch Release Certification by the Central Drugs Laboratory in Kasauli, Himachal Pradesh, under the Ministry of Health and Family Welfare. 'The strengths of innovation and large-scale, high-quality manufacturing are the hallmarks of the Indian vaccine ecosystem. COVID-19 vaccines manufactured in India were largely responsible for not only controlling the COVID-19 pandemic and restricting its impact on lives, livelihoods, but most importantly, enabling India's economic activity and GDP to rebound and grow to new heights globally,' Dr Harshavardhan said. 'This positive impact of COVID-19 vaccination was not only limited to India, but also to several countries worldwide, under the Government of India's Vaccine Maitri programme…,' he added.
Time of India
3 hours ago
- Time of India
Hassan heart attack death cases: India's top drugmakers rally behind Covid vaccines
Leading drugmakers on Thursday rallied in support of Covid vaccines , using various social media platforms, amid a series of deaths in Karnataka's Hassan district due to heart attacks. Dilip Shanghvi, chairman and managing director at Sun Pharmaceuticals said in a post on LinkedIn, 'The deaths of multiple young individuals in one district of Karnataka due to cardiac ailments are unfortunate. While this appears to be specific to the district, linking it to the Covid-19 vaccine without any scientific evidence is "incorrect and misleading". "India's vaccine approval process is rigorous and science-driven, and we must continue to have confidence in it. The vaccine has been administered to millions across the country. If there were a connection, we would have seen similar incidents in many other places — which is not the case. The State health authorities should thoroughly investigate the situation to determine the cause,' Sanghavi said. Sorting to allay the apprehensions, Pankaj Patel, chairman, Zydus Lifesciences , which also manufactures Covid DNA vaccine, said in a post on X, 'There are other multiple reasons like age, environmental factors, genetics, lifestyle etc, that could be the leading cause of heart attacks in people. Several scientific studies globally and in India have conclusively shown that the risk of heart attack or myocarditis is greater after SARS-CoV-2 infection. #Vaccines save lives.' Appreciating the vaccination programme, Patel said, "the massive vaccination programme in our country during the peak of Covid phase saved millions of people and families. In fact a study published in Lancet estimated that India averted almost 3.4 million deaths due to vaccination in the year 2021," he said. Live Events Satish Reddy, chairman, Dr Reddy's Laboratories, wrote, 'India-made vaccines are by WHO and used worldwide. They helped end polio and fight Covid. At a time when India is seen as a vaccine leader, let's build trust in science, not doubt it. Public health must stay above politics.' A post on X attributed to Samir Mehta, executive chairman, Torrent Pharma said, 'India has earned global recognition as the Pharmacy of the World, supplying safe and effective vaccines to over 90 countries…Let's not allow misinformation to erode trust in science or the integrity of India's healthcare ecosystem.' Responding to rising concerns over the sudden deaths of more than 20 people in Hassan district, the Karnataka health department formed an expert committee to probe a possible link to Covid vaccines. However, support came pouring in for Covid vaccines. The Indian Vaccine Manufacturers Association said Covid-19 vaccines were developed and manufactured in the country with the highest safety and quality standards. Assuring about the safety of these vaccines, Dr/ G.V.J.A. Harshavardhan, director general at the association said the approvals were based on extensive evaluation in preclinical studies and human clinical trials with positive results on safety, efficacy, and immunogenicity of the vaccines. 'Patient safety and product quality are always prioritised during the vaccine development and its manufacture,' he said in a statement. He said prior to releasing the vaccines, they were tested extensively for safety by the manufacturers and are also provided batch release certification by the Central Drugs Laboratory (CDL) of the Ministry of Health and Family Welfare. Sudarshan Jain, secretary general, Indian Pharmaceutical Alliance (IPA) said during the pandemic, vaccines played a crucial role, and India consistently supplied medicines and vaccines across the world. "These vaccines have been well documented and rigorously tested as per regulatory processes. Misinformation and distortion of facts endanger public health and undermine the trust built on science and patient care globally".
